2022 Guidelines for Preventive Treatment of Tuberculosis in China

Title: 2022 Guidelines for Preventive Treatment of Tuberculosis in China
Edition: Original
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: China
Guidelines users: This guideline applies to all levels of medical institutions. This guideline is intended for use by TB physicians, infectious disease physicians, rheumatologists, transplant physicians, hemodialysis physicians, and healthcare professionals associated with the diagnosis and management of LTBI.
Evidence classification method: GRADE method of grading evidence
Development unit: 中华医学会结核病学分会;国家感染性疾病临床医学研究中心;深圳市第三人民医院
Registration time: 2022-05-08
Registration number: IPGRP-2022CN256
Purpose of the guideline: Establish the prevention, intervention and management of latent tuberculosis infection in China, in order to guide clinicians and relevant nursing staff to promote the control and management of latent tuberculosis infection in China.